Financial News
Articles published by Alvotech
Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio®
September 25, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 26, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of 2024
August 15, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe
July 22, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Announces Closing of Private Debt Financing
July 11, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Announces Record Preliminary Results for Revenues and EBITDA for the Second Quarter of 2024
July 01, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD in Europe
June 18, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Announces Strategic Refinancing Agreement
June 07, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
May 21, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Announces Increase in Number of Own Shares
March 22, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET
March 05, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Appoints Interim Chief Quality Officer
February 29, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.